Chemed (CHE) Operating Expenses (2009 - 2026)

Chemed has reported Operating Expenses for 18 years, with the latest figure at $572.9 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 3.76% year-over-year to $572.9 million; the trailing twelve-month figure through Mar 2026 stood at $2.2 billion (up 5.35% YoY), and the FY2025 full-year result was $2.2 billion, up 6.15% from the prior year.
• Operating Expenses for Q1 2026 stood at $572.9 million, up from $538.7 million in the prior quarter.
• The five-year high for Operating Expenses was $572.9 million in Q1 2026, with the low at $439.4 million in Q2 2022.
• Average Operating Expenses over 5 years is $502.6 million, with a median of $507.8 million recorded in 2024.
• Year-over-year, Operating Expenses fell 4.6% in 2022 and grew 10.87% in 2024.
• Tracing CHE's Operating Expenses over 5 years: stood at $465.3 million in 2022, then climbed by 1.98% to $474.5 million in 2023, then increased by 10.87% to $526.1 million in 2024, then rose by 2.39% to $538.7 million in 2025, then advanced by 6.36% to $572.9 million in 2026.
• The last three Operating Expenses figures came in at $572.9 million (Q1 2026), $538.7 million (Q4 2025), and $550.2 million (Q3 2025), per Business Quant data.

Peer Comparison